SLC25A51 promotes tumor growth through sustaining mitochondria acetylation homeostasis and proline biogenesis.

ABSTRACT: Solute carrier family 25 member 51 (SLC25A51) was recently identified as the mammalian mitochondrial NAD+ transporter essential for mitochondria functions. However, the role of SLC25A51 in human disease, such as cancer, remains undefined. Here, we report that SLC25A51 is upregulated in multiple cancers, which promotes cancer cells proliferation. Loss of SLC25A51 elevates the mitochondrial proteins acetylation levels due to SIRT3 dysfunctions, leading to the impairment of P5CS enzymatic activity, which is the key enzyme in proline biogenesis, and the reduction in proline contents. Notably, we find fludarabine phosphate, an FDA-approved drug, is able to bind with and inhibit SLC25A51 functions, causing mitochondrial NAD⁺ decrease and proteins hyperacetylation, which could further

SUBMITTER: Li Y 

PROVIDER: S-EPMC10406869 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature